Iranian researchers test gold nanoparticle cancer drug delivery

Nanomedicine researchers at Lorestan University in Iran say they've made progress with a new drug delivery mechanism designed to carry targeted non-chemotherapy cancer treatments. Their design calls for loading the anti-cancer drug onto a gold nanomaterial and then covering it with polymer nanolayers, the Iranian Students' News Agency reports. This process, they report, is designed to use the gold to transfer a specific light wavelength to heat. That, in turn, destroys the nanostructure layers and releases the medicine at a specific target. So far, early tests have allowed the special drug to smash cancer cells without hurting healthy tissue, unlike chemotherapy. Story

Suggested Articles

Armed with microrobots and magnetic fields, Pursue scientists are looking to the future of targeted drug delivery, starting with the colon.

Zosano will need to run additional studies and await an FDA inspection to address the agency's complete response letter on its migraine patch Qtrypta.

Nanoform Finland tapped Quotient Sciences to help run the first in-human trial of a drug developed using its 'nanoforming' technology later this year.